SGMT · Sagimet Biosciences Inc. · Executive Compensation

$10.41 -0.01 (-0.10%)

Russell 2000 member Rebalance outlook locked

Market Cap

$599.83M

62.16M

Volume · Oct 27 1.11M Avg daily vol (3M) 1.32M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Happel	President and Chief Executive Officer	$630,000	—	$546,360	$1,749,751	$294,525	$19,358	$3,239,994
Elizabeth Rozek	Chief Legal and Administrative Officer	$483,333	—	$235,137	$591,668	$170,000	$16,564	$1,496,702
Eduardo Bruno Martins	M.D., D.Phil., Former Chief Medical Officer	$500,000	—	$160,140	$511,580	$170,000	$19,121	$1,360,841

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thierry Chauche	Chief Financial Officer	$314,545	—	—	$1,966,704	$125,721	$506	$2,407,476
David Happel	President and Chief Executive Officer	$582,000	—	—	—	$320,100	$4,064	$906,164
Eduardo Bruno Martins	M.D., D.Phil., Chief Medical Officer	$475,000	—	—	—	$190,000	$4,064	$669,064
Elizabeth Rozek	Chief Legal and Administrative Officer	$446,000	—	—	—	$178,400	$1,742	$626,142

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Happel	President and Chief Executive Officer	$502,894	—	$1,849,734	—	$329,725	$3,564	$2,685,917
Eduardo Bruno Martins	M.D., D.Phil., Chief Medical Officer	$442,930	—	$265,127	$594,620	$202,840	$3,564	$1,509,081
Thierry Chauche	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Happel	President and Chief Executive Officer	$97,917	—	—	$6,198,479	$211,500	$297	$6,508,193
George Kemble	Executive Chairman and former President, Chief Executive Officer and Chief Scientific Officer	$404,856	—	—	$129,713	—	$40,297	$574,866
Eduardo Bruno Martins	M.D., D.Phil., Chief Medical Officer	$411,083	—	—	—	$125,750	$297	$537,130
Dennis Hom	Former Chief Financial Officer	$357,473	—	—	—	$109,351	$68	$466,892

Executive changes

Person	Role	Change	Effective	Filed
Tim Walbert	member of the Board of Directors	Resigned	2026-06-12	2026-06-12
Andreas Grauer, M.D.	Chief Medical Officer	Appointed	2026-04-20	2026-04-21
Eduardo Martins, M.D., D.Phil.	Chief Medical Officer	Retired	2026-04-20	2026-04-21
Beth Seidenberg, M.D.	Class II director	Appointed	2025-06-09	2025-06-10
Elizabeth Grammer	Class II director	Appointed	2025-06-09	2025-06-10
Anne Phillips	director	Appointed	2024-08-01	2024-08-01
Jennifer Jarrett	director	Appointed	2024-08-01	2024-08-01
Thierry Chauche	Chief Financial Officer	Appointed	2024-05-06	2024-05-06
Paul Hoelscher	director	Appointed	2024-04-01	2024-03-25
Tim Walbert	director	Appointed	2024-04-01	2024-03-25
Joseph Oriti	Interim Principal Accounting Officer	Appointed	2024-02-01	2024-02-02
Joseph Oriti	Interim Principal Financial Officer	Appointed	2024-02-01	2024-02-02
Anthony Rimac	Chief Financial Officer	Resigned	2024-01-31	2024-02-02
Anthony Rimac	Chief Financial Officer	Resigned	2024-01-31	2023-12-29
Anthony Rimac	Chief Financial Officer, principal financial officer and principal accounting officer	Appointed	2023-08-01	2023-07-27

Leadership

David Happel CEO, Board Member
George Kemble Chairman, Board Member
Anthony Rimac CFO, Chief Accounting Officer
Dennis Hom CFO
Joseph Oriti CFO, Chief Accounting Officer
Thierry Chauche CFO
Elizabeth Rozek General Counsel
Anne Phillips Board Member
Beth Seidenberg, M.D. Board Member
Jennifer Jarrett Board Member
Tim Walbert Board Member

Key facts CIK 1400118 CUSIP 786700104 13F (30d) 13 filings 13 filers Visit website Investor relations